Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Exploring the benefits and risks of owner-financing in real estate transactions.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Pat founded The Practical Planner, LLC in 1999.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Unveiling the Realm of Long-Term Wealth: IFM's Vision for Financial Prosperity | David Neal, CEO , IFM Investors.
00:10:00
Zuora Subscribed 2017 | Tien Tzuo, CEO, Zuora IncZUO:NYQ
00:00:00
René C. Goehrum | Chairman, President & Chief Executive Officer, Biosyent Inc
00:10:00
A Message of Resilience and Hope from Eurowag CEO Martin Vohánka | Martin Vohánka, CEO, W.A.G. Payment Solutions PLC.
00:10:00
Achieving Financial Freedom with Eric Anderhub | Eric Anderhub, Advisor, Cornerstone Wealth Management.
00:10:00
Cenergy Holdings: €0.08 dividend per share with a €3 billion backlog | Alexios Alexiou, CEO, Cenergy Holdings SACENER:BRU
00:10:00
investment vehicle to empower historically overlooked people and market|Alison Rapaport Stillman,Partner,Serena Ventures
00:10:00
DS Smith Purpose: Insights from CEO Miles Roberts | Miles W. Roberts - CEO of DS Smith
00:10:00
Remote Resilience: Lazard CEO on Dealmaking During Covid-19 | Kenneth M. Jacobs - Executive Chairman at Lazard Asset Management
00:10:00
How Charlie Guides Clients to Achieve Their Life Goals Through Financial Planning | CHARLIE BOLOGNINO - Founder of Side-By-Side Financial Planning, LLC
00:00:00
Interviews Jens Lindberg, CEO Medivir at the Swiss Nordic Bio conference in Zürich, Switzerland - Jens Lindberg, CEO, Medivir
00:00:00
Genetic Technologies building pathway to profitability - Simon Morriss, CEO, Genetic Technologies Ltd